AnaptysBio Announces Positive Top-Line Proof-of-Concept Data For ANB020 In Moderate-to-Severe Baseline
Pharmaceutical Investing Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Pharmaceutical Investing Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update
Pharmaceutical Investing Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update
Pharmaceutical Investing Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update
Skyharbour Partner Company Terra Clean Energy Completes Winter Drill Program with Encouraging Results and Prepares a Significant Summer Drill Program at the South Falcon East Uranium Project
Riverside Resources Moves Ahead on Plan to Spin Out Blue Jay to Shareholders After Approval at the Annual and Special Meeting
1911 Gold Intersects up to 14.97 g/t Gold over 2.70 m including 71.60 g/t Au over 0.50 m on SAM Southeast Zone at True North
